|
|
List of sponsors 
If you are interested in sponsorship opportunities at this event then please contact:
Joyce Harmon, General Manager
Email: Joyce.Harmon@terrapinn.com
Tel: 0207 827 5984
Fax: 0207 242 1508
|
Gold sponsor
|
Invitrogen provides essential life science technologies and services for disease research, drug discovery, and commercial bio-production. Invitrogen's own research and development efforts are focused on breakthrough innovation in all major areas of biological discovery including functional genomics, proteomics, bio-informatics and cell biology-placing Invitrogen's products in nearly every major laboratory in the world. Through its Bioproduction business Invitrogen focuses on all aspects of the production of biotherapeutics, from early stage process development with it's PD Direct process offering, to testing and bioprocess validation undertaken by BioReliance through to the widest product offering of catalogue and specifically tailored cell culture formulations for up stream cell culture. For more information about Invitrogen, visit the company's web site at www.invitrogen.com.
|
Pall Corporation is the global leader in the rapidly growing field of filtration, separations and purification, especially in the biopharmaceutical industry for the production of biotech and biopharmaceutical products.
Pall's Life Sciences Group is fully integrated to offer product lines that start in the laboratory with drug discovery, gene manipulation and proteomics applications, and extend into drug development, process scale up, through to full drug manufacturing production and patient delivery. Pall's extensive expertise helps its customers throughout the drug approval regulatory process, and its filtration systems and validation services offer drug manufacturers the quickest and surest path through the regulatory process and onto the market. As Mr Jerold M. Martin, Senior Vice President and Global Technical Director for Pall Life Sciences' BioPharmaceuticals division said, "Pall Corporation is committed to developing the most advanced, cost-effective virus filtration products that maximize customers' opportunity for success."
|
Associate sponsor
|
Eden Biodesign is a unique biologics contract manufacturer and fully integrated biopharmaceutical development organisation. Our role is to design, develop and deliver valuable biopharmaceutical medicines through the application of good science from day one. Eden has completed successful assignments for over 75 biotech and pharma clients in Europe, Japan, USA and Australasia.
Eden Biodesign operates a state of the art £34 million facility in Liverpool, UK that provides a full range of services for biopharmaceuticals: process development, clinical trials cGMP manufacturing and analytical development for all significant biopharmaceutical product technologies - mammalian, microbial and viral to a worldwide client base.
Our world class facility consists of:
* 3 dedicated process development * 3 segregated cGMP suites designed for rapid, flexible and robust manufacturing
* 6 separated QC and analytical testing laboratories
* cGMP capacity for up to 100 litres for microbial products, 200 litres for mammalian and 20 litres for viral
* Designed to be fully compliant with EU and USA cGMP guidelines
|
Prometic Biosciences Ltd (PBL) is an innovative company bringing new technologies, products and processes that enable the production of higher quality, safer and less expensive therapeutic products. Prometic’s Mimetic Ligand™ technology is used to capture and purify biological compounds, and to remove toxic or pathogenic agents.
|
Novozymes Delta Ltd is a wholly owned subsidiary of Novozymes A/S, Denmark. We supply Recombumin®, the world's first and only recombinant human albumin made to GMP and whose use is approved by FDA and EMEA in the manufacture of a human vaccine - the measles, mumps, rubella product from Merck & Co and SPMSD.
We are also developing a range of animal-free ingredients for use in cell culture media, including recombinant human albumin and transferrin. In addition we licence our proprietary protein expression system based on Saccharomyces cerevisiae for the production of therapeutic proteins or vaccines.
Visit us at Stand 12 to discuss your vaccine manufacturing requirements.
|
Synco BioPartners is one of Europes leading Contract Manufacturing Organizations. Focusing exclusively on Biopharmaceuticals and Vaccines, Synco offers a complete range of manufacturing services including fermentation development, downstream process development, assay development and CGMP manufacture for Phase I-III clinical trials and market supply. Synco also offers a filling and lyophilization service, again to CGMP. Synco has an extensive track record of succesful manufacturing project, and is currently engaged in the manufacture of APIs for clinical trials and for European market supply.
|
|
|
|
